news details |
|
|
| Heart Treatment Without Stents: Can Balloon Technology Change the Future of Cardiac Care? | | | Medical science is continuously developing new and innovative ways to treat heart diseases. Among the major advances in cardiology is the use of balloon-based techniques to treat narrowed or blocked coronary arteries. Traditionally, many patients with coronary artery disease have been treated with angioplasty followed by the placement of a stent. However, newer technologies, particularly drug-coated balloons, are creating possibilities for treating selected patients without leaving a permanent metallic implant inside the artery.
This development has raised an important question: Can balloon technology become an effective alternative to stents and transform the future of heart treatment?
### How Does Balloon-Based Treatment Work?
A drug-coated balloon (DCB) is a specialised medical device designed to open narrowed coronary arteries. During the procedure, a thin catheter carrying the balloon is guided through a blood vessel towards the affected area of the heart.
Once the balloon reaches the narrowed section, it is carefully inflated to widen the artery and improve blood flow. Unlike a conventional stent procedure, the balloon is then removed without leaving a permanent metallic structure behind.
The special feature of a drug-coated balloon is that its surface contains medication that is transferred to the artery wall during inflation. This medicine helps prevent excessive growth of cells that can cause the artery to narrow again.
The approach is often described as a “leave-nothing-behind” strategy because it avoids placing a permanent implant in the treated section of the artery. PMC +1
### Advantages of Drug-Coated Balloon Technology
Drug-coated balloons offer several potential advantages for appropriately selected patients.
* No permanent metallic implant: The treated artery does not need to contain an additional metal stent.
* Preservation of natural artery movement: The artery may retain more of its natural flexibility and ability to respond to changes in blood flow.
* Reduced metal burden: This can be particularly useful for patients who have already received multiple stents.
* Potentially shorter medication requirements: Some patients may need a shorter duration of dual antiplatelet therapy, although the treatment duration depends on individual clinical circumstances.
* Useful for small arteries: Balloon-based treatment can be particularly beneficial in certain small coronary vessels where placing a stent may be technically challenging.
These advantages make the technology an important development in interventional cardiology. Springer Nature Link +2
### Where Can This Technology Be Used?
Drug-coated balloons are particularly useful in treating in-stent restenosis, a condition in which an artery becomes narrow again inside a previously implanted stent.
They are also increasingly being used for selected cases of coronary artery disease involving small blood vessels. In these situations, avoiding another permanent implant may offer clinical advantages.
However, not every patient is suitable for balloon-only treatment. The success of the procedure depends on the location, size and severity of the blockage, the condition of the artery and the patient’s overall health.
If the artery does not remain sufficiently open after balloon treatment, the cardiologist may need to insert a stent to ensure adequate blood flow. Springer Nature Link +2
### Is Balloon Treatment as Effective as Stenting?
This is one of the most important questions in modern cardiac care. Research comparing drug-coated balloons with drug-eluting stents has produced encouraging but mixed results.
Some clinical studies suggest that balloon treatment can provide comparable outcomes in carefully selected patients, particularly those with small-vessel disease. However, other studies indicate that drug-eluting stents offer better protection against the need for repeat treatment in certain coronary lesions.
A 2026 review published in npj Cardiovascular Health highlights that drug-coated balloons have important applications but that their effectiveness varies according to the type and location of the blockage.
For many patients with larger coronary arteries and complex blockages, drug-eluting stents remain an established standard treatment. Therefore, balloon technology should be considered an additional treatment option rather than a universal replacement for stents. PMC +2
### Challenges and Future Possibilities
Although balloon technology has made considerable progress, certain challenges remain. Successful treatment requires careful preparation of the narrowed artery, appropriate selection of the balloon and considerable expertise on the part of the cardiologist.
Researchers are also working to improve drug coatings, develop better balloon materials and identify which patients are most likely to benefit from stent-free procedures.
Advances in medical imaging, artificial intelligence and personalised treatment planning may further improve the selection of suitable patients and the safety of these procedures.
In the coming years, a combination of balloon-based treatment and selective stent placement may become an increasingly important approach in personalised cardiac care
Drug-coated balloon technology represents an important step forward in the treatment of coronary artery disease. It offers the possibility of opening narrowed arteries, delivering medication directly to the affected area and avoiding a permanent metallic implant in selected patients.
However, the future of heart treatment is unlikely to depend on one technique alone. Stents and drug-coated balloons will continue to have complementary roles in modern cardiology.
The ultimate objective of medical science should not simply be to introduce newer devices but to provide safer, more effective and affordable treatment tailored to each patient’s needs.
The real achievement of modern cardiac care will be measured not by the number of stents avoided, but by the number of lives protected and the quality of life restored.
Dr. Vijay Garg Retired Principal | Eminent Scientist Street Kaur Chand, MHR Malout, Punjab – 152107 Mobile: 9465682110 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
 |
|
|
